TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
8.85
-0.02 (-0.23%)
Sep 24, 2026, 1:30 PM CST
| Market Cap | 6.30B +2.4% |
| Revenue (ttm) | 256.46M +530.4% |
| Net Income | 155.12M |
| EPS | 0.21 |
| Shares Out | 711.83M |
| PE Ratio | 41.81 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 393,547 |
| Open | 8.99 |
| Previous Close | 8.87 |
| Day's Range | 8.80 - 8.99 |
| 52-Week Range | 7.73 - 16.40 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |